| Absorption |
| Blood-Brain Barrier | BBB- | 0.9893 |
| Human Intestinal Absorption | HIA- | 0.7376 |
| Caco-2 Permeability | Caco2- | 0.6208 |
| P-glycoprotein Substrate | Substrate | 0.9292 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9211 |
| Non-inhibitor | 0.6582 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8738 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5526 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7747 |
| CYP450 2D6 Substrate | Non-substrate | 0.8136 |
| CYP450 3A4 Substrate | Substrate | 0.6766 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9123 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8593 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9265 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9699 |
| Inhibitor | 0.5732 |
| AMES Toxicity | Non AMES toxic | 0.6718 |
| Carcinogens | Non-carcinogens | 0.9182 |
| Fish Toxicity | High FHMT | 0.9933 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9526 |
| Honey Bee Toxicity | Low HBT | 0.6340 |
| Biodegradation | Not ready biodegradable | 0.8673 |
| Acute Oral Toxicity | III | 0.6905 |
| Carcinogenicity (Three-class) | Non-required | 0.6402 |